Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

BCRXBCRX
Showing 8 of 29 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in BIOCRYST PHARMACEUTICALS INC

JANE STREET GROUP, LLC holds 2.8M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $27.6M as of 2026-Q2. The position was increased (+343.7% shares). BCRX represents 0.0% of JANE STREET GROUP, LLC's portfolio.

Current Value

$27.6M

Current Shares

2.8M

Total Value Change

+$22.2M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.8M
+343.7%
$27.6M0.0%$10.00
46
2026-Q1
Decreased
622,607
-4.1%
$5.9M0.0%$9.52
0
2025-Q4
Decreased
649,357
-64.9%
$5.1M0.0%$7.80
0
2025-Q3
Increased
1.8M
+563.7%
$14M0.0%$7.59
45
2025-Q2
Decreased
278,498
-42.7%
$2.5M0.0%$8.96
0
2025-Q1
Decreased
485,809
-15.1%
$3.6M0.0%$7.50
0
2024-Q4
Decreased
572,346
-19.6%
$4.3M0.0%$7.52
0
2024-Q3
Decreased
711,425
-15.3%
$5.4M0.0%$7.60
0

Other major holders of BCRX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used